References
- Chen Y, Sun XB, Lu HE, Wang F, Fan XH. Effect of luteoin in delaying cataract in STZ-induced diabetic rats. Arch Pharm Res. 2017;40(1):88–95. doi:https://doi.org/10.1007/s12272-015-0669-5.
- Manikandan R, Thiagarajan R, Beulaja S, Chindhu S, Mariammal K, Sudhandiran G, Arumugam M. Anti-cataractogenic effect of curcumin and aminoguanidine against selenium-induced oxidative stress in the eye lens of wistar rat pups: an in vitro study using isolated lens. Chem Biol Interact. 2009;181(2):202–09. doi:https://doi.org/10.1016/j.cbi.2009.05.011.
- Raman R, Pal SS, Adams JSK, Rani PK, Vaitheeswaran K, Sharma T. Prevalence and risk factors for cataract in diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetics Study, report no. 17. Invest Ophthalmol Vis Sci. 2010;51(12):6253–61. doi:https://doi.org/10.1167/iovs.10-5414.
- Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes. 2015;6(1):92–108. doi:https://doi.org/10.4239/wjd.v6.i1.92.
- Pollreisz A, Schmidt-Erfurth U. Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol. 2010;2010:1–8. doi:https://doi.org/10.1155/2010/608751.
- Sai Varsha MK, Raman T, Manikandan R. Inhibition of diabetic-cataract by vitamin K1 involves modulation of hyperglycemia-induced alterations to lens calcium homeostasis. Exp Eye Res. 2014;128:73–82. doi:https://doi.org/10.1016/j.exer.2014.09.007.
- Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res. 2007;2007:61038. doi:https://doi.org/10.1155/2007/61038.
- Szkudelski T, Szkudelska K. Resveratrol and diabetes: from animal to human studies. Biochim Biophys Acta. 2015;1852(6):1145–54. doi:https://doi.org/10.1016/j.bbadis.2014.10.013.
- Taysi S, Okumus S, Akyuz M, Uzun N, Aksoy A, Demir E, Orkmez M, Tarakcioglu M, Adli M. Zinc administration modulates radiation-induced oxidative injury in lens of rat. Pharmacogn Mag. 2012;8(32):245–49. doi:https://doi.org/10.4103/0973-1296.103646.
- Goutham G, Manikandan R, Beulaja M, Thiagarajan R, Arulvasu C, Arumugam M, Setzer WN, Daglia M, Nabavi SF, Nabavi SM. A focus on resveratrol and ocular problems, especially cataract: from chemistry to medical uses and clinical relevance. Biomed Pharmacother. 2017;86:232–41. doi:https://doi.org/10.1016/j.biopha.2016.11.141.
- Chen Y, Meng J, Li H, Wei H, Bi F, Liu S, Tang K, Guo H, Liu W. Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via pon1. Exp Eye Res. 2019;181:356–66. doi:https://doi.org/10.1016/j.exer.2018.11.023.
- Smith AJO, Eldred JA, Wormstone IM. Resveratrol inhibits wound healing and lens fibrosis: A putative candidate for posterior capsule opacification prevention. Invest Ophthalmol Vis Sci. 2019;60(12):3863–77. doi:https://doi.org/10.1167/iovs.18-26248.
- Winnik S, Auwerx J, Sinclair DA, Matter CM. Protective effects of sirtuins in cardiovascular diseases: from bench to bedside. Eur Heart J. 2015;36(48):3404–12. doi:https://doi.org/10.1093/eurheartj/ehv290.
- Singh A, Bodakhe SH. Resveratrol delay the cataract formation against naphthalene-induced experimental cataract in the albino rats. J Biochem Mol Toxicol. 2020;34(1):e22420. doi:https://doi.org/10.1002/jbt.22420.
- Jangra A, Datusalia AK, Khandwe S, Sharma SS. Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: implication of oxidative stress-parp pathway. Pharmacol Biochem Behav. 2013;114-115:43–51. doi:https://doi.org/10.1016/j.pbb.2013.10.021.
- Lam TT. The effect of 3-aminobenzamide, an inhibitor of poly-ADP-ribose polymerase, on ischemia/reperfusion damage in rat retina. Res Commun Mol Pathol Pharmacol. 1997;95:241–52.
- Negi G, Kumar A, Kaundal RK, Gulati A, Sharma SS. Functional and biochemical evidence indicating beneficial effect of melatonin and nicotinamide alone and in combination in experimental diabetic neuropathy. Neuropharmacology. 2010;58(3):585–92. doi:https://doi.org/10.1016/j.neuropharm.2009.11.018.
- Gencoglu H, Tuzcu M, Hayirli A, Sahin K. Protective effects of resveratrol against streptozotocin-induced diabetes in rats by modulation of visfatin/sirtuin-1 pathway and glucose transporters. Int J Food Sci Nutr. 2015;66(3):314–20. doi:https://doi.org/10.3109/09637486.2014.1003534.
- Kilari EK, Putta S. Delayed progression of diabetic cataractogenesis and retinopathy by litchi chinensis in STZ-induced diabetic rats. Cutan Ocul Toxicol. 2017;36(1):52–59. doi:https://doi.org/10.3109/15569527.2016.1144610.
- Sanderson J, Marcantonio JM, Duncan G. A human lens model of cortical cataract: Ca2+-induced protein loss, vimentin cleavage and opacification. Invest Ophthalmol Vis Sci. 2000;41:2255–61.
- Khan SA, Choudhary R, Singh A, Bodakhe SH. Hypertension potentiates cataractogenesis in rat eye through modulation of oxidative stress and electrolyte homeostasis. J Curr Ophthalmol. 2016;28(3):123–30. doi:https://doi.org/10.1016/j.joco.2016.05.001.
- Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972;47(2):389–94. doi:https://doi.org/10.1016/0003-2697(72)90132-7.
- Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984;21:130–32.
- Tappel AL. Glutathione peroxidase and hydroperoxides. Methods Enzymol. 1978;52:506–13.
- Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–77. doi:https://doi.org/10.1016/0003-9861(59)90090-6.
- Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351–58. doi:https://doi.org/10.1016/0003-2697(79)90738-3.
- Hayman S, Kinoshita JH. Isolation and properties of lens aldose reductase. J Biol Chem. 1965;240:877–82.
- Thiraphatthanavong P, Wattanathorn J, Muchimapura S, Wipawee TM, Wannanon P, Terdthai TU, Suriharn B, Lertrat K. Preventive effect of Zea mays l. (purple waxy corn) on experimental diabetic cataract. Biomed Res Int. 2014;2014:507435. doi:https://doi.org/10.1155/2014/507435.
- Khorsand M, Akmali M, Sharzad S, Beheshtitabar M. Melatonin reduces cataract formation and aldose reductase activity in lenses of streptozotocin-induced diabetic rat. Iran J Med Sci. 2016;41:305–13.
- Yadav A, Choudhary R, Bodakhe SH. Role of nitric oxide in the development of cataract formation in CdCl2-induced hypertensive animals. Curr Eye Res. 2018;43(12):1454–64. doi:https://doi.org/10.1080/02713683.2018.1501490.
- Nisselbaum JS, Green S. A simple ultramicro method for determination of pyridine nucleotides in tissues. Anal Biochem. 1969;27(2):212–17. doi:https://doi.org/10.1016/0003-2697(69)90025-6.
- Bhadada SV, Bhadada VJ, Goyal RK. Preventive effect of Tephrosia purpurea on selenite-induced experimental cataract. Curr Eye Res. 2016;41(2):222–31. doi:https://doi.org/10.3109/02713683.2015.1011281.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265–75.
- Wang Y, Qin S, Pen G, Chen D, Han C, Miao C, Lu B, Su C, Feng S, Li W, et al. Original research: potential ocular protection and dynamic observation of polygonatum sibiricum polysaccharide against streptozocin-induced diabetic rats’ model. Exp Biol Med (Maywood). 2017;242(1):92–101. doi:https://doi.org/10.1177/1535370216663866.
- Shree J, Choudhary R, Bodakhe SH. Losartan delays the progression of streptozotocin-induced diabetic cataracts in albino rats. J Biochem Mol Toxicol. 2019;33(8):e22342. doi:https://doi.org/10.1002/jbt.22342
- Ido Y. Diabetic complications within the context of aging: nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3. J Diabetes Investig. 2016;7(4):448–58. doi:https://doi.org/10.1111/jdi.12485.
- Drel VR, Xu W, Zhang J, Kador PF, Ali TK, Shin J, Julius U, Slusher B, El-Remessy AB, Obrosova IG. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats. Invest Ophthalmol Vis Sci. 2009;50(4):1778–90. doi:https://doi.org/10.1167/iovs.08-2191.
- Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007;404(1):1–13. doi:https://doi.org/10.1042/BJ20070140.
- Longo VD, Kennedy BK. Sirtuins in aging and age-related disease. Cell. 2006;126(2):257–68. doi:https://doi.org/10.1016/j.cell.2006.07.002.
- Suryanarayana P, Saraswat M, Mrudula T, Krishna TP, Krishnaswamy K, Reddy GB. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthalmol Vis Sci. 2005;46(6):2092–99. doi:https://doi.org/10.1167/iovs.04-1304.
- Grant R. Resveratrol increases intracellular NAD+ levels through up regulation of the NAD+ synthetic enzyme nicotinamide mononucleotide adenylyltransferase. Nat Prec. 2010. doi:https://doi.org/10.1038/npre.2010.4421.1.
- Imai S-I, Guarente L. It takes two to tango: NAD(+) and sirtuins in aging/longevity control. NPJ Aging Mech Dis. 2016;2:16017–16017. doi:https://doi.org/10.1038/npjamd.2016.17.
- Chung HT, Joe Y. Antagonistic crosstalk between SIRT1, PARP-1, and -2 in the regulation of chronic inflammation associated with aging and metabolic diseases. Integr Med Res. 2014;3(4):198–203. doi:https://doi.org/10.1016/j.imr.2014.09.005.
- Smith AJO, Ball SSR, Bowater RP, Wormstone IM. PARP-1 inhibition influences the oxidative stress response of the human lens. Redox Biol. 2016;8:354–62. doi:https://doi.org/10.1016/j.redox.2016.03.003.
- Langelier MF, Pascal JM. PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis. Curr Opin Struct Biol. 2013;23(1):134–43. doi:https://doi.org/10.1016/j.sbi.2013.01.003.
- Nogueiras R, Habegger KM, Chaudhary N, Finan B, Banks AS, Dietrich MO, Horvath TL, Sinclair DA, Pfluger PT, Tschop MH. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev. 2012;92(3):1479–514. doi:https://doi.org/10.1152/physrev.00022.2011.
- Mishra M, Kowluru RA. Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy. Biochim Biophys Acta Mol Basis Dis. 2017;1863(7):1761–69. doi:https://doi.org/10.1016/j.bbadis.2017.04.024.
- Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, et al. PARP-1 inhibition increases mitochondrial metabolism through sirt1 activation. Cell Metab. 2011;13(4):461–68. doi:https://doi.org/10.1016/j.cmet.2011.03.004.
- Agarwal R, Iezhitsa L, Agarwal P. Pathogenetic role of magnesium deficiency in ophthalmic diseases. Biometals. 2014;27:5–18. doi:https://doi.org/10.1007/s10534-013-9684-5.
- Pescosolido N, Barbato A, Giannotti R, Komaiha C, Lenarduzzi F. Age-related changes in the kinetics of human lenses: prevention of the cataract. Int J Ophthalmol. 2016;9(10):1506–17. doi:https://doi.org/10.18240/ijo.2016.10.23.
- Gupta PD, Johar K, Vasavada A. Causative and preventive action of calcium in cataracto-genesis. Acta Pharmacol Sin. 2004;25:1250–56.
- Klinger S, Breves G. Resveratrol inhibits porcine intestinal glucose and alanine transport: potential roles of Na+/K+-ATPase activity, protein kinase a, amp-activated protein kinase and the association of selected nutrient transport proteins with detergent resistant membranes. Nutrients. 2018;10:302.
- Singh A, Bodakhe SH. Resveratrol delay the cataract formation against naphthalene-induced experimental cataract in the albino rats. J Biochem Mol Toxicol. 2020;34(1):e22420 doi:https://doi.org/10.1002/jbt.22420.
- Vora D, Heruye S, Kumari D, Opere C, Chauhan H. Preparation, characterization and antioxidant evaluation of poorly soluble polyphenol-loaded nanoparticles for cataract treatment. AAPS PharmSciTech. 2019;20(5):163. doi:https://doi.org/10.1208/s12249-019-1379-y.
- Ito Y, Nabekura T, Takeda M, Nakao M, Terao M, Hori R, Tomohiro M. Nitric oxide participates in cataract development in selenite-treated rats. Curr Eye Res. 2001;22(3):215–20. doi:https://doi.org/10.1076/ceyr.22.3.215.5516.
- Drago F, Bucolo C. Therapeutic potential of nitric oxide modulation in ocular diseases. Drug News Perspect. 2010;23(7):430–37. doi:https://doi.org/10.1358/dnp.2010.23.7.1484488.
- Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404(6779):787–90. doi:https://doi.org/10.1038/35008121.
- Stadtman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci. 2000;899:191–208. doi:https://doi.org/10.1111/j.1749-6632.2000.tb06187.x.